Approved a dividend of 3.95 Swiss francs per share to be paid on May 28, 2009 to shareholders of record on May 11, 2009 .

From a recent Mad Money show:"Not bad, not bad, but I want to be in Allergan (AGN). They've got a lot of different products and I think they're stronger than yours."

From a recent Mad Money show:"Not bad, not bad, but I want to be in Allergan (AGN). They've got a lot of different products and I think they're stronger than yours."

From a recent Mad Money show:"Not bad, not bad, but I want to be in Allergan (AGN). They've got a lot of different products and I think they're stronger than yours."

stable

Swiss eye care products maker Alcon Inc. said Tuesday it plans to buy back up to 1 million shares from investors before the end of the year.

About 70 million, or 23 percent, of Alcon's 300 million outstanding shares are publicly traded. The company said it would use the proceeds to pay employee compensation plans.

Earlier this year Alcon suspended share repurchasing after Swiss pharmaceutical maker Novartis purchased a 25 percent stake in the company from its parent Nestle SA. Currently, Nestle holds a 52 percent stake in Alcon.

Plastic Surgery First, Mortgage Second: People are struggling to pay their home and car loans but refuse to sacrifice plastic surgery. The business is booming as people find ways to finance their beauty makeovers.

Click here to watch the video.

Q: You like Alcon.



A: My Alcon price target will go to $176 with my 10% discount rate for 2009. So I get $160 to $165, and the stock is at $145.

0.9%

it is a company that I am familiar with at work.

Slow growth

Formerly Lucent. OMG Lucent. Could a management team have wrecked a greater company with so much potential.